| Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of 18F-FDG Uptake at PET—Association with Treatment Response and Prognosis GJR Cook, ME O’Brien, M Siddique, S Chicklore, HY Loi, B Sharma, ... Radiology 276 (3), 883-893, 2015 | 186 | 2015 |
| The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI G Kong, C Jackson, DM Koh, V Lewington, B Sharma, G Brown, ... European journal of nuclear medicine and molecular imaging 35, 1323-1329, 2008 | 168 | 2008 |
| Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation U Khalid, A Spiro, C Baldwin, B Sharma, C McGough, AR Norman, ... Supportive care in cancer 15, 39-46, 2007 | 168 | 2007 |
| Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? C Pawlyn, L Fowkes, S Otero, JR Jones, KD Boyd, FE Davies, GJ Morgan, ... Leukemia 30 (6), 1446-1448, 2016 | 160 | 2016 |
| PET/CT in oncology—a major advance K Wechalekar, B Sharma, G Cook Clinical radiology 60 (11), 1143-1155, 2005 | 124 | 2005 |
| Regulation of the activity of human chymase during storage and release from mast cells: the contributions of inorganic cations, pH, heparin and histamine AR McEuen, B Sharma, AF Walls Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1267 (2-3), 115-121, 1995 | 102 | 1995 |
| Effective grid connected power injection scheme using multilevel inverter based hybrid wind solar energy conversion system B Sharma, R Dahiya, J Nakka Electric Power Systems Research 171, 1-14, 2019 | 95 | 2019 |
| CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial M Gleeson, C Peckitt, YM To, L Edwards, J Oates, A Wotherspoon, ... The Lancet Haematology 5 (5), e190-e200, 2018 | 75 | 2018 |
| Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma YK Lee, G Cook, MA Flower, C Rowbottom, M Shahidi, B Sharma, ... Radiotherapy and oncology 73 (3), 277-283, 2004 | 75 | 2004 |
| Breast implant–associated anaplastic large cell lymphoma: review and multiparametric imaging paradigms B Sharma, A Jurgensen-Rauch, E Pace, AD Attygalle, R Sharma, ... Radiographics 40 (3), 609-628, 2020 | 68 | 2020 |
| Positron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer: a large retrospective study from the Royal Marsden Hospital A Constantinidou, A Martin, B Sharma, SRD Johnston Annals of oncology 22 (2), 307-314, 2011 | 56 | 2011 |
| Positron Emission Tomography - Computed Tomography in Liver Imaging B Sharma, A Martin, I Zerizer Seminars in Ultrasound, CT and MRI 34 (1), 66-80, 2013 | 50 | 2013 |
| Single‐phase cascaded multilevel inverter topology addressed with the problem of unequal photovoltaic power distribution in isolated dc links B Sharma, J Nakka IET Power Electronics 12 (2), 284-294, 2019 | 44 | 2019 |
| Evolution of lymphoma staging and response evaluation: current limitations and future directions J Cunningham, S Iyengar, B Sharma Nature Reviews Clinical Oncology 14 (10), 631-645, 2017 | 41 | 2017 |
| Significance of life skills education. Contemporary Issues in Education Research, 10 (1), 1-6 R Prajapati, B Sharma, D Sharma | 40 | 2017 |
| UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products … NM P Turton, D El-Sharkawi, I Lyburn, B Sharma, P Mahalingham, SD Turner, F ... Journal of Plastic, Reconstructive and Aesthetic Surgery 74 (1), 13-29, 2020 | 39* | 2020 |
| Prospective evaluation of whole-body MRI versus FDG PET/CT for lesion detection in participants with myeloma C Messiou, N Porta, B Sharma, D Levine, DM Koh, K Boyd, C Pawlyn, ... Radiology: Imaging Cancer 3 (5), e210048, 2021 | 36 | 2021 |
| Handbook of metastatic breast cancer C Swanton, SRD Johnston CRC Press, 2011 | 35 | 2011 |
| Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer KL Newbold, M Partridge, G Cook, B Sharma, P Rhys-Evans, ... Acta Oncologica 47 (7), 1229-1236, 2008 | 34 | 2008 |
| A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12 weeks MER O’Brien, JS Myerson, JIG Coward, M Puglisi, L Trani, ... European Journal of Cancer 48 (1), 68-74, 2012 | 33 | 2012 |
